nach oben

Erschienen in:

27.01.2022 | Original Article

Outcome of healing after dental implant placement in patients with cancer on high-dose antiresorptive medications: a prospective feasibility study

verfasst von: Sanne Werner Møller Andersen, Camilla Ottesen, Klaus Gotfredsen, Simon Storgård Jensen, Thomas Kofod, Morten Schiodt

Erschienen in: Oral and Maxillofacial Surgery | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Implant placement in patients with cancer receiving high-dose antiresorptive medication (HDAR) is considered contraindicated. This prospective, feasibility study tested the hypothesis that dental implants can be placed in such patients by applying a staged implant placement protocol with submerged healing.

Methods

Three groups of patients on HDAR were included as follows: group 1: patients who underwent tooth extraction, without the development of medication-related osteonecrosis of the jaws (MRONJ); group 2: patients with surgically treated MRONJ who had demonstrated clinical healing for at least 3 months; group 3: patients with established MRONJ who was planned for surgical resection and simultaneous implant placement.

Results

A total of 49 implants were placed in 27 patients (group 1: 12, group 2: 7 and group 3: 8). HDAR included bisphosphonates and denosumab. The mean HDAR time was 25 months (SD: ± 18.4, range 3–68 months). An abutment operation was performed 4 months following the implant placement (SD: ± 1.9, range 3–14 months). All patients healed uneventfully.

Conclusions

This study demonstrated that it is feasible to insert dental implants and perform an abutment surgery in patients with cancer on HDAR, without the development of MRONJ.

Trial registration.

ClinicalTrials.gov Identifier: NCT04741906.

Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115–1117. https://doi.org/10.1016/s0278-2391(03)00720-1CrossRefPubMed

Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O’Ryan F (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw–2014 update. J Oral Maxillofac Surg 72(10):1938–1956. https://doi.org/10.1016/j.joms.2014.04.031CrossRefPubMed

Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL (2004) Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg 62(5):527–534. https://doi.org/10.1016/j.joms.2004.02.004CrossRefPubMed

Ruggiero S, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, Toth B, Damato K, Valero V (2006) Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Pract 2(1):7–14. https://doi.org/10.1200/jop.2006.2.1.7CrossRefPubMedPubMedCentral

Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B (2009) American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update. Aust Endod J 35(3):119–130. https://doi.org/10.1111/j.1747-4477.2009.00213.xCrossRefPubMed

Schiodt M, Reibel J, Oturai P, Kofod T (2014) Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system. Oral Surg Oral Med Oral Pathol Oral Radiol 117(2):204–213. https://doi.org/10.1016/j.oooo.2013.10.010CrossRefPubMed

Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiødt M (2018) Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev 69:177–187. https://doi.org/10.1016/j.ctrv.2018.06.007CrossRefPubMed

Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O’Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, Al Dabagh R, Davison KS, Kendler DL, Sándor GK, Josse RG, Bhandari M, El Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30(1):3–23. https://doi.org/10.1002/jbmr.2405CrossRefPubMed

Nicolatou-Galitis O, Schiødt M, Mendes RA, Ripamonti C, Hope S, Drudge-Coates L, Niepel D, Van den Wyngaert T (2019) Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 127(2):117–135. https://doi.org/10.1016/j.oooo.2018.09.008CrossRefPubMed

10.

Otto S, Troltzsch M, Jambrovic V, Panya S, Probst F, Ristow O, Ehrenfeld M, Pautke C (2015) Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development? J Craniomaxillofac Surg 43(6):847–854. https://doi.org/10.1016/j.jcms.2015.03.039CrossRefPubMed

11.

Heufelder MJ, Hendricks J, Remmerbach T, Frerich B, Hemprich A, Wilde F (2014) Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 117(6):e429-435. https://doi.org/10.1016/j.oooo.2012.08.442CrossRefPubMed

12.

Yazdi PM, Schiodt M (2015) Dentoalveolar trauma and minor trauma as precipitating factors for medication-related osteonecrosis of the jaw (ONJ): a retrospective study of 149 consecutive patients from the Copenhagen ONJ Cohort. Oral Surg Oral Med Oral Pathol Oral Radiol 119(4):416–422. https://doi.org/10.1016/j.oooo.2014.12.024CrossRefPubMed

13.

Werner S, Andersen M, Jensen S, Schiodt M (2020) Apical surgery in cancer patients receiving high-dose antiresorptive medication—a retrospective clinical study with a mean follow-up of 13 months. Oral Maxillofac Surg. https://doi.org/10.1007/s10006-020-00909-9CrossRef

14.

Gotfredsen K, Wiskott A (2012) Consensus report - reconstructions on implants. The Third EAO Consensus Conference 2012. Clin Oral Implants Res 23 Suppl 6:238–241. doi:https://doi.org/10.1111/j.1600-0501.2012.02549.x

15.

Jung RE, Zembic A, Pjetursson BE, Zwahlen M, Thoma DS (2012) Systematic review of the survival rate and the incidence of biological, technical, and aesthetic complications of single crowns on implants reported in longitudinal studies with a mean follow-up of 5 years. Clin Oral Implants Res 23(Suppl 6):2–21. https://doi.org/10.1111/j.1600-0501.2012.02547.xCrossRefPubMed

16.

Buser D, Janner SF, Wittneben JG, Brägger U, Ramseier CA, Salvi GE (2012) 10-year survival and success rates of 511 titanium implants with a sandblasted and acid-etched surface: a retrospective study in 303 partially edentulous patients. Clin Implant Dent Relat Res 14(6):839–851. https://doi.org/10.1111/j.1708-8208.2012.00456.xCrossRefPubMed

17.

Hjalmarsson L, Gheisarifar M, Jemt T (2016) A systematic review of survival of single implants as presented in longitudinal studies with a follow-up of at least 10 years. Eur J Oral Implantol 9(Suppl 1):S155-162PubMed

18.

Walter C, Al-Nawas B, Wolff T, Schiegnitz E, Grotz KA (2016) Dental implants in patients treated with antiresorptive medication - a systematic literature review. Int J Implant Dent 2(1):9. https://doi.org/10.1186/s40729-016-0041-7CrossRefPubMedPubMedCentral

19.

Schliephake H, Sicilia A, Nawas BA, Donos N, Gruber R, Jepsen S, Milinkovic I, Mombelli A, Navarro JM, Quirynen M, Rocchietta I, Schiodt M, Schou S, Stahli A, Stavropoulos A (2018) Drugs and diseases: summary and consensus statements of group 1. The 5(th) EAO Consensus Conference 2018. Clin Oral Implants Res 29 Suppl 18:93–99. doi:https://doi.org/10.1111/clr.13270

20.

Stavropoulos A, Bertl K, Pietschmann P, Pandis N, Schiødt M, Klinge B (2018) The effect of antiresorptive drugs on implant therapy: systematic review and meta-analysis. Clin Oral Implants Res 29(Suppl 1):54–92. https://doi.org/10.1111/clr.13282CrossRefPubMed

21.

Holzinger D, Seemann R, Matoni N, Ewers R, Millesi W (1937) Wutzl A (2014) Effect of dental implants on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 72(10):e1931-1938. https://doi.org/10.1016/j.joms.2014.04.037CrossRef

22.

Tam Y, Kar K, Nowzari H, Cha HS, Ahn KM (2014) Osteonecrosis of the jaw after implant surgery in patients treated with bisphosphonates–a presentation of six consecutive cases. Clin Implant Dent Relat Res 16(5):751–761. https://doi.org/10.1111/cid.12048CrossRefPubMed

23.

Kwon TG, Lee CO, Park JW, Choi SY, Rijal G, Shin HI (2014) Osteonecrosis associated with dental implants in patients undergoing bisphosphonate treatment. Clin Oral Implants Res 25(5):632–640. https://doi.org/10.1111/clr.12088CrossRefPubMed

24.

Jacobsen C, Metzler P, Rossle M, Obwegeser J, Zemann W, Gratz KW (2013) Osteopathology induced by bisphosphonates and dental implants: clinical observations. Clin Oral Investig 17(1):167–175. https://doi.org/10.1007/s00784-012-0708-2CrossRefPubMed

25.

Lazarovici TS, Yahalom R, Taicher S, Schwartz-Arad D, Peleg O, Yarom N (2010) Bisphosphonate-related osteonecrosis of the jaw associated with dental implants. J Oral Maxillofac Surg 68(4):790–796. https://doi.org/10.1016/j.joms.2009.09.017CrossRefPubMed

26.

Heitz-Mayfield LJ, Aaboe M, Araujo M, Carrion JB, Cavalcanti R, Cionca N, Cochran D, Darby I, Funakoshi E, Gierthmuehlen PC, Hashim D, Jahangiri L, Kwon Y, Lambert F, Layton DM, Lorenzana ER, McKenna G, Mombelli A, Muller F, Roccuzzo M, Salvi GE, Schimmel M, Srinivasan M, Tomasi C, Yeo A (2018) Group 4 ITI Consensus Report: Risks and biologic complications associated with implant dentistry. Clin Oral Implants Res 29(Suppl 16):351–358. https://doi.org/10.1111/clr.13307CrossRefPubMed

27.

Schimmel M, Srinivasan M, McKenna G, Muller F (2018) Effect of advanced age and/or systemic medical conditions on dental implant survival: a systematic review and meta-analysis. Clin Oral Implants Res 29(Suppl 16):311–330. https://doi.org/10.1111/clr.13288CrossRefPubMed

28.

Chappuis V, Avila-Ortiz G, Araújo MG, Monje A (2018) Medication-related dental implant failure: systematic review and meta-analysis. Clin Oral Implants Res 29(Suppl 16):55–68. https://doi.org/10.1111/clr.13137CrossRefPubMed

29.

Jung RE, Al-Nawas B, Araujo M, Avila-Ortiz G, Barter S, Brodala N, Chappuis V, Chen B, De Souza A, Almeida RF, Fickl S, Finelle G, Ganeles J, Gholami H, Hammerle C, Jensen S, Jokstad A, Katsuyama H, Kleinheinz J, Kunavisarut C, Mardas N, Monje A, Papaspyridakos P, Payer M, Schiegnitz E, Smeets R, Stefanini M, Ten Bruggenkate C, Vazouras K, Weber HP, Weingart D, Windisch P (2018) Group 1 ITI Consensus Report: The influence of implant length and design and medications on clinical and patient-reported outcomes. Clin Oral Implants Res 29(Suppl 16):69–77. https://doi.org/10.1111/clr.13342CrossRefPubMed

30.

Marx RE, Sawatari Y, Fortin M, Broumand V (2005) Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 63(11):1567–1575. https://doi.org/10.1016/j.joms.2005.07.010CrossRefPubMed

31.

Fugazzotto PA, Lightfoot WS, Jaffin R, Kumar A (2007) Implant placement with or without simultaneous tooth extraction in patients taking oral bisphosphonates: postoperative healing, early follow-up, and the incidence of complications in two private practices. J Periodontol 78(9):1664–1669. https://doi.org/10.1902/jop.2007.060514CrossRefPubMed

32.

Grant BT, Amenedo C, Freeman K, Kraut RA (2008) Outcomes of placing dental implants in patients taking oral bisphosphonates: a review of 115 cases. J Oral Maxillofac Surg 66(2):223–230. https://doi.org/10.1016/j.joms.2007.09.019CrossRefPubMed

33.

Ata-Ali J, Ata-Ali F, Penarrocha-Oltra D, Galindo-Moreno P (2016) What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis. Clin Oral Implants Res 27(2):e38-46. https://doi.org/10.1111/clr.12526CrossRefPubMed

34.

Giovannacci I, Meleti M, Manfredi M, Mortellaro C, Greco Lucchina A, Bonanini M, Vescovi P (2016) Medication-related osteonecrosis of the jaw around dental implants: implant surgery-triggered or implant presence-triggered osteonecrosis? J Craniofac Surg 27(3):697–701. https://doi.org/10.1097/scs.0000000000002564CrossRefPubMed

35.

Escobedo MF, Cobo JL, Junquera S, Milla J, Olay S, Junquera LM (2020) Medication-related osteonecrosis of the jaw. Implant presence-triggered osteonecrosis: Case series and literature review. J Stomatol Oral Maxillofac Surg 121 (1):40–48. doi:https://doi.org/10.1016/j.jormas.2019.04.012

36.

van Kampen FM, van der Bilt A, Cune MS, Fontijn-Tekamp FA, Bosman F (2004) Masticatory function with implant-supported overdentures. J Dent Res 83(9):708–711. https://doi.org/10.1177/154405910408300910CrossRefPubMed

37.

Fueki K, Kimoto K, Ogawa T, Garrett NR (2007) Effect of implant-supported or retained dentures on masticatory performance: a systematic review. J Prosthet Dent 98(6):470–477. https://doi.org/10.1016/s0022-3913(07)60147-4CrossRefPubMed

38.

DeBaz C, Hahn J, Lang L, Palomo L (2015) Dental implant supported restorations improve quality of life in osteoporotic women. Int J Dent 2015:451923. https://doi.org/10.1155/2015/451923CrossRefPubMedPubMedCentral

39.

Müller F, Schädler M, Wahlmann U, Newton JP (2004) The use of implant-supported prostheses in the functional and psychosocial rehabilitation of tumor patients. Int J Prosthodont 17(5):512–517PubMed

40.

Amgen Europe (2015) Xgeva (denosumab) summary of product characteristics. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002173/WC500110381.pdf. October 20, 2021

41.

Kimmel DB (2007) Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res 86(11):1022–1033. https://doi.org/10.1177/154405910708601102CrossRefPubMed

42.

Wongchuensoontorn C, Liebehenschel N, Wagner K, Fakler O, Gutwald R, Schmelzeisen R, Sauerbier S (2009) Pathological fractures in patients caused by bisphosphonate-related osteonecrosis of the jaws: report of 3 cases. J Oral Maxillofac Surg 67(6):1311–1316. https://doi.org/10.1016/j.joms.2008.12.030CrossRefPubMed

43.

Ottesen C, Schiodt M, Jensen SS, Kofod T, Gotfredsen K (2021) Tooth extractions in patients with cancer receiving high-dose antiresorptive medication: a randomized clinical feasibility trial of drug holiday versus drug continuation. Oral Surg Oral Med Oral Pathol Oral Radiol. https://doi.org/10.1016/j.oooo.2021.06.003CrossRefPubMed

Titel: Outcome of healing after dental implant placement in patients with cancer on high-dose antiresorptive medications: a prospective feasibility study
verfasst von: Sanne Werner Møller Andersen
Camilla Ottesen
Klaus Gotfredsen
Simon Storgård Jensen
Thomas Kofod
Morten Schiodt
Publikationsdatum: 27.01.2022
Verlag: Springer Berlin Heidelberg
Erschienen in: Oral and Maxillofacial Surgery / Ausgabe 1/2023
Print ISSN: 1865-1550
Elektronische ISSN: 1865-1569
DOI: https://doi.org/10.1007/s10006-022-01042-5

Neu im Fachgebiet Chirurgie

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Outcome of healing after dental implant placement in patients with cancer on high-dose antiresorptive medications: a prospective feasibility study